Market Overview

The Global Genomics in Cancer Care Market was valued at USD 15,037.3 million in 2023 and is expected to reach USD 55,195.8 million by 2031 while growing at a CAGR of 17.7% during the forecast period (2024-2031). 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global genomics in cancer care market growth. Genomics in cancer care involves applying genomic information to understand and address cancer. It includes analyzing the genetic material of cancer cells to identify genetic alterations, guiding personalized treatment, predicting responses to therapies, and identifying potential therapeutic targets.

Advancements in Genomic Technologies and the rising global prevalence of cancer are set to drive the genomics in cancer care market. However, challenges such as the high cost of genomic testing and inadequate reimbursement policies may impede market growth.

Furthermore, the global genomics in cancer care industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Product Type Analysis

The Global Genomics in Cancer Care Market is segmented among Instruments, Consumables, and Services, based on Product Type. In 2023, Consumables accounted for the majority of the market share*. 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By Technology Analysis

The Global Genomics in Cancer Care Market is segmented among PCR, Microarrays, and Genome Sequencing, based on Technology. In 2023, Genome Sequencing accounted for the majority of the market share*. 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Genomics in Cancer Care Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031). 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Agilent Technologies, Inc., Cancer Genetics Inc., GE Healthcare (GE Company), Merck KGaA, Illumina Inc., Intrexon Bioinformatics Germany GmbH, Pacific Biosciences of California, Inc., Quest Diagnostics, F. Hoffmann-La Roche AG, and ThermoFisher Scientific Inc.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Genomics in Cancer Care Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Genomics in Cancer Care Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Genomics in Cancer Care Market Segmentation, By Product Type

• Global Genomics in Cancer Care Market Share Analysis, By Product Type

• Global Genomics in Cancer Care Market Growth Analysis, By Product Type

• Global Genomics in Cancer Care Market Trends, By Product Type

o Instruments

o Consumables

o Services

6. Global Genomics in Cancer Care Market Segmentation, By Technology

• Global Genomics in Cancer Care Market Share Analysis, By Technology

• Global Genomics in Cancer Care Market Growth Analysis, By Technology

• Global Genomics in Cancer Care Market Trends, By Technology

o PCR

o MicroArrays

o Genome Sequencing

7. Global Genomics in Cancer Care Market Segmentation, By Region

• Global Genomics in Cancer Care Market Share Analysis, By Region

• Global Genomics in Cancer Care Market Growth Analysis, By Region

• Global Genomics in Cancer Care Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

8. Competitive Landscape

• Agilent Technologies, Inc.*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• Cancer Genetics Inc.

• GE Healthcare (GE Company)

• Merck KGaA

• Illumina Inc.

• Intrexon Bioinformatics Germany GmbH

• Pacific Biosciences of California, Inc.

• Quest Diagnostics

• F. Hoffmann-La Roche AG

• ThermoFisher Scientific Inc.

*Similar analysis will be provided for each company listed above.